Cardiol Therapeutics Inc.

NASDAQ:CRDL

1.08 (USD) • At close April 28, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017
Operating Activities:
Net Income -36.677-0.028-30.931-31.638-20.641-13.684-15.894-1.661
Depreciation & Amortization 0.37300.220.220.230.1510.0910.053
Deferred Income Tax 00-9.161-4.916007.8820
Stock Based Compensation 14.2774.1735.0138.4982.7653.2661.6530
Change In Working Capital -0.9320.0015.7480.0778.316-1.621-5.2020.048
Accounts Receivables -0.0820-0.144-0.060.708-0.467-0.359-0.102
Inventory 00-4.4750.0181.1010.143-0.0060
Accounts Payables 004.4752.393-0.7080.4671.9650.177
Other Working Capital -0.850.0015.892-2.2757.215-1.763-7.167-0.128
Other Non Cash Items -2.103-4.1711.894.2090.1450.5080.5750.267
Operating Cash Flow -25.061-0.025-27.22-23.551-9.185-11.38-10.894-1.292
Investing Activities:
Investments In Property Plant And Equipment -0.021-0-0.075-0.013-0.041-0.424-0.014-0.029
Acquisitions Net 00000000
Purchases Of Investments 00000000
Sales Maturities Of Investments 00000000
Other Investing Activites 0000000-0.007
Investing Cash Flow -0.021-0-0.075-0.013-0.041-0.424-0.014-0.029
Financing Activities:
Debt Repayment -0.042-0.055-0.054-0.052-0.05-0.0212.0690.4
Common Stock Issued 21.3560084.08417.251.66714.2343.398
Common Stock Repurchased 00000000
Dividends Paid 00000000
Other Financing Activities -2.4740.055-09.406-0.9050.382-1.02-0.121
Financing Cash Flow 18.84-0-0.05493.43816.2952.02925.2833.678
Other Information:
Effect Of Forex Changes On Cash 1.890.0012.92-0.011-0.056000
Net Change In Cash -4.352-0.025-24.42969.8747.069-9.77514.3752.357
Cash At End Of Period 30.580.03559.4783.89914.0256.95616.7322.357